-
摘要: 缺铁性贫血(iron deficiency anemia，IDA)是最常见的贫血类型，铁缺乏患者即使尚未发生贫血也可表现出组织细胞铁缺乏的相关症状，导致严重后果。血清铁蛋白 < 15 μg/L表明机体储存铁已然耗竭，而 < 30 μg/L通常认为储存铁即已明显减低。IDA铁剂治疗也受到铁稳态调节影响。选择合适的一线补铁治疗方法的关键是识别出不适于口服补铁的患者。血清铁调素水平与口服铁剂吸收呈负相关，口服铁剂治疗IDA应避免每日多次给药，IDA现代静脉补铁治疗更为安全、有效。Abstract: Iron deficiency anemia is the most common type of anemia. Iron deficiency, even in the absence of anemia, can be debilitating, and exacerbate any underlying chronic disease. A serum ferritin < 30 μg/L is generally considered to have significantly reduced iron storage, while < 15 μg/L indicates that the body has depleted iron stores. Iron replacement therapy is affected by iron homeostasis regulation. The key to choosing appropriate first-line iron therapy is to identify patients who are not candidates for oral iron supplementation. Serum hepcidin levels are inversely correlated with oral iron absorption, and multiple daily doses should be avoided for oral iron therapy. Modern intravenous iron therapy is safer and more effective.
-
Key words:
- anemia /
- iron deficiency /
- diagnosis /
- iron replacement therapy
-
-
[1] Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010[J]. Blood, 2014, 123(5): 615-624. doi: 10.1182/blood-2013-06-508325
[2] GHO. Global Health Observatory data repository 2016[EB/OL].
http://apps.who.int/gho/data/node.home .[3] Safiri S, Kolahi AA, Noori M, et al. Burden of anemia and its underlying causes in 204 countries and territories, 1990-2019: Results from the Global Burden of Disease Study 2019[J]. J Hematol Oncol, 2021, 14(1): 185. doi: 10.1186/s13045-021-01202-2
[4] Weyand AC, Chaitoff A, Freed GL, et al. Prevalence of Iron Deficiency and Iron-Deficiency Anemia in US Females Aged 12-21 Years, 2003-2020[J]. JAMA, 2023, 329(24): 2191-2193. doi: 10.1001/jama.2023.8020
[5] Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review[J]. Am J Clin Nutr, 2015, 102(6): 1585-1594. doi: 10.3945/ajcn.114.103366
[6] Camaschella C. Iron-deficiency anemia[J]. N Engl J Med, 2015, 372(19): 1832-1843. doi: 10.1056/NEJMra1401038
[7] Camaschella C. Iron deficiency[J]. Blood, 2019, 133(1): 30-39. doi: 10.1182/blood-2018-05-815944
[8] Charlebois E, Fillebeen C, Presley J, et al. Liver sinusoidal endothelial cells induce BMP6 expression in response to non-transferrin-bound iron[J]. Blood, 2023, 141(3): 271-284. doi: 10.1182/blood.2022016987
[9] Corradini E, Meynard D, Wu Q, et al. Serum and liver iron differently regulate the bone morphogenetic protein 6(BMP6)-SMAD signaling pathway in mice[J]. Hepatology, 2011, 54(1): 273-284. doi: 10.1002/hep.24359
[10] Pasricha SR, Lim PJ, Duarte TL, et al. Hepcidin is regulated by promoter-associated histone acetylation and HDAC3[J]. Nat Commun, 2017, 8(1): 403. doi: 10.1038/s41467-017-00500-z
[11] Rockey DC, Altayar O, Falck-Ytter Y, et al. AGA Technical Review on Gastrointestinal Evaluation of Iron Deficiency Anemia[J]. Gastroenterology, 2020, 159(3): 1097-1119. doi: 10.1053/j.gastro.2020.06.045
[12] Lopez A, Cacoub P, Macdougall IC, et al. Iron deficiency anaemia[J]. Lancet, 2016, 387(10021): 907-916. doi: 10.1016/S0140-6736(15)60865-0
[13] Klip IT, Comin-Colet J, Voors AA, et al. Iron deficiency in chronic heart failure: an international pooled analysis[J]. Am Heart J, 2013, 165(4): 575-582. doi: 10.1016/j.ahj.2013.01.017
[14] McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease[J]. Curr Med Res Opin, 2004, 20(9): 1501-1510. doi: 10.1185/030079904X2763
[15] Cappellini MD, Comin-Colet J, de Francisco A, et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management[J]. Am J Hematol, 2017, 92(10): 1068-1078. doi: 10.1002/ajh.24820
[16] Guagnozzi D, Lucendo AJ. Anemia in inflammatory bowel disease: a neglected issue with relevant effects[J]. World J Gastroenterol, 2014, 20(13): 3542-3551. doi: 10.3748/wjg.v20.i13.3542
[17] Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases[J]. J Crohns Colitis, 2015, 9(3): 211-222. doi: 10.1093/ecco-jcc/jju009
[18] Musallam KM, Taher AT. Iron deficiency beyond erythropoiesis: should we be concerned?[J]. Curr Med Res Opin, 2018, 34(1): 81-93. doi: 10.1080/03007995.2017.1394833
[19] Fernandez-Jimenez MC, Moreno G, Wright I, et al. Iron deficiency in menstruating adult women: Much more than anemia[J]. Womens Health Rep, 2020, 1(1): 26-35.
[20] Balendran S, Forsyth C. Non-anaemic iron deficiency[J]. Aust Prescr, 2021, 44(6): 193-196. doi: 10.18773/austprescr.2021.052
[21] Soppi ET. Iron deficiency without anemia-A clinical challenge[J]. Clin Case Rep, 2018, 6(6): 1082-1086. doi: 10.1002/ccr3.1529
[22] Pfeiffer CM, Looker AC. Laboratory methodologies for indicators of iron status: strengths, limitations, and analytical challenges[J]. Am J Clin Nutr, 2017, 106(suppl 6): 1606S-1614S. doi: 10.3945/ajcn.117.155887
[23] Houston BL, Hurrie D, Graham J, et al. Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: a systematic review of randomised controlled trials[J]. BMJ Open, 2018, 8(4): e019240. doi: 10.1136/bmjopen-2017-019240
[24] Charles-Edwards G, Amaral N, Sleigh A, et al. Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency: FERRIC-HF Ⅱ randomized mechanistic trial[J]. Circulation, 2019, 139(21): 2386-2398. doi: 10.1161/CIRCULATIONAHA.118.038516
[25] Bregman DB, Morris D, Koch TA, et al. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia[J]. Am J Hematol, 2013, 88(2): 97-101. doi: 10.1002/ajh.23354
[26] Girelli D, Ugolini S, Busti F, et al. Modern iron replacement therapy: clinical and pathophysiological insights[J]. Int J Hematol, 2018, 107(1): 16-30. doi: 10.1007/s12185-017-2373-3
[27] Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women[J]. Blood, 2015, 126(17): 1981-1989. doi: 10.1182/blood-2015-05-642223
[28] Young MF, Glahn RP, Ariza-Nieto M, et al. Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women[J]. Am J Clin Nutr, 2009, 89(2): 533-538. doi: 10.3945/ajcn.2008.26589
[29] Sangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin[J]. Adv Nutr, 2017, 8(1): 126-136. doi: 10.3945/an.116.013961
[30] Zimmermann MB, Troesch B, Biebinger R, et al. Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin[J]. Am J Clin Nutr, 2009, 90(5): 1280-1287. doi: 10.3945/ajcn.2009.28129
[31] Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials[J]. Lancet Haematol, 2017, 4(11): e524-e533. doi: 10.1016/S2352-3026(17)30182-5
[32] Mehta S, Sharma BS, Gulati S, et al. A prospective, randomized, interventional study of oral iron supplementation comparing daily dose with alternate day regimen using hepcidin as a biomarker in iron deficiency anemia[J]. J Assoc Physicians India, 2020, 68(5): 39-41.
[33] Auerbach M, Gafter-Gvili A, Macdougall IC, et al. Intravenous iron: a framework for changing the management of iron deficiency[J]. Lancet Haematol, 2020, 7(4): e342-e350. doi: 10.1016/S2352-3026(19)30264-9
-
计量
- 文章访问数: 2490
- PDF下载数: 8131
- 施引文献: 0
下载: